English
Home > Products > CAS NO 7211-39-4

China CAS NO 7211-39-4 Factory

High quality Very first,and Shopper Supreme is our guideline to offer the most beneficial company to our clients.Nowadays, we're hoping our best to be certainly one of the top exporters in our area to satisfy consumers additional will need for CAS NO 7211-39-4,7211-39-4,Brigatinib intermediate,Brigatinib advance intermediate,Dimethylphosphine oxide, Sincerely hope we're increasing up along with our buyers all around the entire world.
CAS NO 7211-39-4, Our domestic website's generated over 50, 000 purchasing orders every year and quite successful for internet shopping in Japan. We would be happy to have an opportunity to do business with your company. Looking forward to receiving your message !

Related Products

Hot Products

  • 4-Aminopyrazolo[3,4-d]pyrimidine

    4-Aminopyrazolo[3,4-d]pyrimidine

    Product Name:4-Aminopyrazolo[3,4-d]pyrimidine
    Molecular Formula:C5H5N5
    Molecular Weight:135.13
    CAS Registry Number:2380-63-4
  • (S)-2-CHLORO-1-PHENYL-ETHANOL

    (S)-2-CHLORO-1-PHENYL-ETHANOL

    Product Name:(S)-2-CHLORO-1-PHENYL-ETHANOL
    Molecular Formula:C8H9ClO
    Molecular Weight:156.61
    CAS Registry Number:70111-05-6
  • Lamivudine

    Lamivudine

    Product Name:Lamivudine
    Molecular Formula:C8H11N3O3S
    Molecular Weight;229.26
    CAS Registry Number;134678-17-4
  • L-Aspartic acid

    L-Aspartic acid

    Product Name:L-Aspartic acid
    Molecular Formula:C4H7NO4
    Molecular Weight;133.1
    CAS Registry Number;56-84-8
  • 4-Androsten-3-one-5-ene-17-carboxylic acid

    4-Androsten-3-one-5-ene-17-carboxylic acid

    Product Name:4-Androsten-3-one-5-ene-17-carboxylic acid
    Molecular Formula:C20H28O3
    Molecular Weight:316.43
    CAS Registry Number:302-97-6
  • Iberdomide

    Iberdomide

    Product Name:Iberdomide
    Molecular Formula:C25H27N3O5
    Molecular Weight;449.5
    CAS Registry Number;1323403-33-3
  • Related Blog
  • Reviews

  • Baloxavir marboxil

    Baloxavir marboxil is used to treat flu symptoms caused by influenza virus in people who have had symptoms for no more than 48 hours. Baloxavir marboxil will not treat the common cold. Baloxavir marboxil is for adults and children who are at least 12 years old and weigh at least 88 pounds (40 kilograms).

  • FDA approves lorlatinib for second- or third-line treatment of ALK-positive metastatic NSCLC

    On November 2, 2018, the Food and Drug Administration granted accelerated approval to lorlatinib (LORBRENA, Pfizer, Inc.) for patients with anaplastic lymphoma kinase (ALK)-positive metastatic non-small cell lung cancer (NSCLC) whose disease has progressed on crizotinib and at least one other ALK inhibitor for metastatic disease or whose disease has progressed on alectinib or ceritinib as the first ALK inhibitor therapy for metastatic disease.

  • Bosutinib CAS 380843-75-4

    Chemical name:4-(2,4-dichloro-5-methoxyanilino)-6-methoxy-7-[3-(4-methylpiperazin-1-yl)propoxy]quinoline-3-carbonitrile

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • Gilteritinib Fumarate

    Sandoo Pharmaceutica is a professional pharmaceutical intermediates manufacturer. We provide good quality Gilteritinib Fumarate Cas: 1254053-43-4. Welcome and we look forward to your inquiry!

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept